Anhui Huaheng Biotechnology Co., Ltd.
SHH: 688639.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Henghua Guo
- Employees
- 2,191
- Headquarters
- Hefei, China
- IPO year
- 2021
- Market cap
- CN¥6.9B
- Website
- https://www.huahengbio.com
Loading 688639…
Loading profile data…Frequently asked questions about 688639
What does Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) do?
Anhui Huaheng Biotechnology Co., Ltd. engages in the development, production, and sale of amino acids and other organic acids in China and internationally. The company offers L-alanine, DL-alanine, beta-alanine, and D-alanine products; and L-aspartic, DL-aspartic, and D-aspartic acids, as well as L-aspartate salt. It also provides various other...
Where does 688639.SS trade?
Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) trades on the Shanghai Stock Exchange.
What sector is 688639.SS in?
Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Anhui Huaheng Biotechnology Co., Ltd.?
Henghua Guo is the chief executive officer of Anhui Huaheng Biotechnology Co., Ltd. (688639.SS).
Where is Anhui Huaheng Biotechnology Co., Ltd. headquartered?
Anhui Huaheng Biotechnology Co., Ltd. is headquartered in China.
Does 688639.SS pay a dividend?
Yes — Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) paid a trailing twelve-month dividend of CNY 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688639.SS go public?
Anhui Huaheng Biotechnology Co., Ltd. (688639.SS) completed its initial public offering in 2021.